Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis

Yu Nishida; Shuhei Hosomi; Hirokazu Yamagami; Tomomi Yukawa; Koji Otani; Yasuaki Nagami; Fumio Tanaka; Koichi Taira; Noriko Kamata; Tetsuya Tanigawa; Masatsugu Shiba; Kenji Watanabe; Toshio Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara

doi:10.1371/journal.pone.0169845

Loading metrics

Open Access

Peer-reviewed

Research Article

Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis

Yu Nishida,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Shuhei Hosomi ,

* E-mail: m1265271@med.osaka-cu.ac.jp

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan

http://orcid.org/0000-0002-8808-5672

⨯
Hirokazu Yamagami,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Tomomi Yukawa,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Koji Otani,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Yasuaki Nagami,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Fumio Tanaka,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Koichi Taira,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Noriko Kamata,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Tetsuya Tanigawa,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Masatsugu Shiba,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Kenji Watanabe,

Affiliations Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan, Department of Gastroenterology, Osaka City General Hospital, Osaka, Japan
⨯
Toshio Watanabe,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Kazunari Tominaga,

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Yasuhiro Fujiwara

Affiliation Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯

Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis

Yu Nishida,
Shuhei Hosomi,
Hirokazu Yamagami,
Tomomi Yukawa,
Koji Otani,
Yasuaki Nagami,
Fumio Tanaka,
Koichi Taira,
Noriko Kamata,
Tetsuya Tanigawa

Published: January 11, 2017
https://doi.org/10.1371/journal.pone.0169845

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Ulcerative colitis
Is the Subject Area "Ulcerative colitis" applicable to this article?

Thanks for your feedback.
Corticosteroid therapy
Is the Subject Area "Corticosteroid therapy" applicable to this article?

Thanks for your feedback.
Neutrophils
Is the Subject Area "Neutrophils" applicable to this article?

Thanks for your feedback.
Inflammatory bowel disease
Is the Subject Area "Inflammatory bowel disease" applicable to this article?

Thanks for your feedback.
C-reactive proteins
Is the Subject Area "C-reactive proteins" applicable to this article?

Thanks for your feedback.
Blood counts
Is the Subject Area "Blood counts" applicable to this article?

Thanks for your feedback.
White blood cells
Is the Subject Area "White blood cells" applicable to this article?

Thanks for your feedback.
Crohn's disease
Is the Subject Area "Crohn's disease" applicable to this article?

Thanks for your feedback.